Plethico Pharmaceuticals Ltd has informed BSE that Natrol Inc. a leading player in the nutraceutical segment has launched its new product Natrol "Immune Boost" for the wellness of Bodys Immune System.
Natrol Inc., USA is a wholly owned subsidiary of Plethico Pharmaceuticals Ltd. The Company has submitted to BSE a detailed Pres Release in this regard.
| NIFTY 
